DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN, PACLITAXEL AND CMF VERSUS EPIRUBICIN, CMF AND WEEKLY DOCETAXEL OR PACLITAXEL FOLLOWED BY TRASTUZUMAB FOR ONE YEAR IN PATIENTS WITH EARLY BREAST CANCER

被引：0
|
作者：
Fountzilas, G. [1 ]
Gogas, H. [1 ]
Pavlidis, N. [1 ]
Eleftheraki, A. [1 ]
Skarlos, D. [1 ]
Koutras, A. [1 ]
Timotheadou, E. [1 ]
Papandreou, C. [1 ]
Pectasides, D. [1 ]
Dimopoulos, M. [1 ]
机构：
[1] Hellen Cooperat Oncol Grp HeCOG, Data Off, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [41] Nab-paclitaxel Followed by Dose-dense Epirubicin/Cyclophosphamide in Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Phase II Study
    Liu, Yin
    Fan, Lei
    Wang, Zhong-Hua
    Shao, Zhi-Ming
    ONCOLOGIST, 2023, 28 (01): : 86 - +
  • [42] Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with early breast cancer with four or more positive lymph nodes
    Murialdo, Roberto
    Gallo, Maurizio
    Boy, Davide
    Zoppoli, Gabriele
    Tixi, Lucia
    Gonella, Roberta
    Ballestrero, Alberto
    Patrone, Franco
    TUMORI JOURNAL, 2014, 100 (02): : 128 - 135
  • [43] Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: A randomized study conducted by the Hellenic Cooperative Oncology Group
    Fountzilas, G
    Papadimitriou, C
    Dafni, U
    Bafaloukos, D
    Skarlos, D
    Moulopouos, LA
    Razis, E
    Kalofonos, HP
    Aravantinos, G
    Briassoulis, E
    Papakostas, P
    Abela, K
    Gogas, E
    Kosmidis, P
    Pavlidis, N
    Dimopoulos, MA
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) : 2232 - 2239
  • [44] Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer
    R I Lalisang
    E E Voest
    J A Wils
    J W Nortier
    F L Erdkamp
    H F Hillen
    J Wals
    H C Schouten
    G H Blijham
    British Journal of Cancer, 2000, 82 : 1914 - 1919
  • [45] Dose-dense epirubicin with paclitaxel as preoperative treatment in locally advanced breast cancer: Phase II trial
    Bautista Aragon, Y. L.
    Silva, J.
    Gonzalez Avila, G.
    Gutierrez, A.
    Pluma-Jimenez, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer
    Lalisang, RI
    Voest, EE
    Wils, JA
    Nortier, JW
    Erdkamp, FL
    Hillen, HF
    Wals, J
    Schouten, HC
    Blijham, GH
    BRITISH JOURNAL OF CANCER, 2000, 82 (12) : 1914 - 1919
  • [47] The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients
    Wu, Xian
    Ye, Chaoran
    Wang, Xingmeng
    Cai, Ruyu
    Yang, Junzhe
    Yu, Xiafei
    Zhou, Yi
    Shen, Li
    Zhu, Yanhui
    Liu, Xiaoan
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 1517 - 1527
  • [48] Neoadjuvant chemotherapy with a dose-dense sequential combination of epirubicin and cyclophosphamide followed by paclitaxel and gemcitabine ± trastuzumab in stage II and III breast cancer. Correlation between pathologic complete response (pCR) and biologic markers
    Sanchez, A.
    Duenas-Garcia, R.
    Jaen-Morago, A.
    Chacon, I.
    Garcia-Tapiador, A.
    Martinez-Ortega, E.
    de la Torre-Cabrera, C.
    Duenas, B.
    Ribelles, N.
    Sanchez-Rovira, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with breast cancer with 4 or more positive lymph nodes
    Boy, D.
    Murialdo, R.
    Angelini, I.
    Panariello, M.
    Tixi, L.
    Sacca, V.
    Piccardo, A.
    Ballestrero, A.
    BREAST, 2009, 18 : S55 - S55
  • [50] Adjuvant treatment of breast cancer patients with 1-3 positive lymph nodes:: vinorelbine plus epirubicin;: vinorelbine plus epirubicin sequential followed up by paclitaxel;: epirubicin plus cyclophosphamide;: epirubicin plus cyclophosphamide sequential followed up by paclitaxel.: A phase II study
    Elling, D
    Eggemann, H
    Kümmel, S
    Breitbach, P
    Kohls, A
    Morack, G
    Schlosser, H
    Krocker, J
    BREAST, 2003, 12 (03): : 208 - 211
12345